Fig. 1.
Expansion of MDSCs in patients with extranodal NK/T cell lymphoma. a Gating routine for MDSC subsets. b–c The dot plots represent the CD33+CD11b+ cell subset, the CD33+CD11b− cell subset and the CD33−CD11b+ cell subset gating on the HLA-DR− fraction among the PBMCs from healthy donors (b) or ENKL patients (c). d–f The statistical analysis of the percentage of the MDSC subsets among the PBMCs from the ENKL patients (n = 32) and healthy donors (n = 32). The error bar represents the SEM. Student’s t test is used. HD healthy donor, ENKL extranodal NK/T cell lymphoma